Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis C

As the first line of treatment for hepatitis C virus (HCV) infection, direct-acting antivirals (DAAs) have greater efficacy and fewer adverse effects than other treatments; however, drug-drug interactions (DDIs) must be avoided when used in combination with other medications, such as statins. HCV pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Meng-Hsuan, Tseng, Chih-Wei, Lee, Chi-Hui, Tseng, Kuo-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605290/
https://www.ncbi.nlm.nih.gov/pubmed/33163377
http://dx.doi.org/10.4103/tcmj.tcmj_247_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605290/
https://www.ncbi.nlm.nih.gov/pubmed/33163377
http://dx.doi.org/10.4103/tcmj.tcmj_247_19

Ejemplares similares